Actin-Titin Interaction in Cardiac Myofibrils: Probing a Physiological Role
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Desmin Forms Toxic, Seeding-Competent Amyloid Aggregates That Persist in Muscle Fibers
Desmin forms toxic, seeding-competent amyloid aggregates that persist in muscle fibers Niraja Kediaa, Khalid Arhzaouyb, Sara K. Pittmanb, Yuanzi Sunc,d, Mark Batchelord, Conrad C. Weihlb,1, and Jan Bieschkea,d,1 aDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63130; bDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110; cDepartment of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, St. Louis, MO 63130; and dUniversity College London Institute of Prion Diseases/Medical Research Council Prion Unit, University College London, London W1W 7FF, United Kingdom Edited by Nancy M. Bonini, University of Pennsylvania, Philadelphia, PA, and approved July 10, 2019 (received for review May 16, 2019) Desmin-associated myofibrillar myopathy (MFM) has pathologic Desmin is a 470-amino acid protein, and more than 70 disease- similarities to neurodegeneration-associated protein aggregate dis- associated mutations have been reported that span the entire eases. Desmin is an abundant muscle-specific intermediate filament, protein (3). The formation of desmin IFs occurs via sequentially and disease mutations lead to its aggregation in cells, animals, and ordered steps that include dimer and tetramer formation, unit- patients. We reasoned that similar to neurodegeneration-associated length filament formation, and filament elongation (5). Some proteins, desmin itself may form amyloid. Desmin peptides corre- disease mutations affect IF assembly in vitro and in vivo, resulting sponding to putative amyloidogenic regions formed seeding- in cytosolic inclusions (5, 6). Similarly, disease mutations in the competent amyloid fibrils. Amyloid formation was increased when small heat shock protein αB crystallin affect its ability to facili- disease-associated mutations were made within the peptide, and tate desmin filament formation, resulting in desmin aggregation this conversion was inhibited by the anti-amyloid compound (7). -
Appropriate Roles of Cardiac Troponins in Evaluating Patients with Chest Pain
J Am Board Fam Pract: first published as 10.3122/jabfm.12.3.214 on 1 May 1999. Downloaded from MEDICAL PRACTICE Appropriate Roles of Cardiac Troponins in Evaluating Patients With Chest Pain Matthew S. Rice, MD, CPT, Me, USA, and David C. MacDonald, DO, Me, USA Background: Diagnosis of acute myocardial infarction relies upon the clinical history, interpretation of the electrocardiogram, and measurement of serum levels of cardiac enzymes. Newer biochemical markers of myocardial injury, such as cardiac troponin I and cardiac troponin T, are now being used instead of or along with the standard markers, the MB isoenzyme of creatine kinase (CK-MB) and lactate dehydrogenase. Methods: We performed a MEDLINE literature search (1987 to 1997) using the key words "troponin I," "troponin T," and "acute myocardial infarction." We reviewed selected articles related to the diagnostic and prognostic usefulness of these cardiac markers in evaluating patients with suspected myocardial infarction. Results: We found that (1) troponin I is a better cardiac marker than CK-MB for myocardial infarction because it is equally sensitive yet more specific for myocardial injury; (2) troponin T is a relatively poorer cardiac marker than CK-MB because it is less sensitive and less specific for myocardial injury; and (3) both troponin I and troponin T may be used as independent prognosticators of future cardiac events. Conclusions: Troponin I is a sensitive and specific marker for myocardial injury and can be used to predict the likelihood of future cardiac events. It is not much more expensive to measure than CK-MB. Over all, troponin I is a better cardiac marker than CK-MB and should become the preferred cardiac enzyme when evaluating patients with suspected myocardial infarction. -
Daam2 Couples Translocation and Clustering of Wnt Receptor Signalosomes Through Rac1 Carlo D
© 2021. Published by The Company of Biologists Ltd | Journal of Cell Science (2021) 134, jcs251140. doi:10.1242/jcs.251140 RESEARCH ARTICLE Daam2 couples translocation and clustering of Wnt receptor signalosomes through Rac1 Carlo D. Cristobal1,QiYe2, Juyeon Jo2, Xiaoyun Ding3, Chih-Yen Wang2, Diego Cortes2, Zheng Chen4 and Hyun Kyoung Lee1,3,5,* ABSTRACT Dynamic polymerization of the Dishevelled proteins functions at Wnt signaling plays a critical role in development across species and the core of the Wnt signalosome by interacting with both the is dysregulated in a host of human diseases. A key step in signal Frizzled Wnt receptors and low-density lipoprotein receptor-related transduction is the formation of Wnt receptor signalosomes, during protein 5/6 (LRP5/6), leading to recruitment of Axin proteins β which a large number of components translocate to the membrane, from the -catenin destruction complex (MacDonald et al., 2009; cluster together and amplify downstream signaling. However, the Schwarz-Romond et al., 2007). However, the exact composition molecular processes that coordinate these events remain poorly and mechanisms of signalosome assembly at the plasma membrane defined. Here, we show that Daam2 regulates canonical Wnt remain unclear. signaling via the PIP –PIP5K axis through its association with Rac1. The hallmark of canonical Wnt signaling is the accumulation and 2 β Clustering of Daam2-mediated Wnt receptor complexes requires both translocation of -catenin into the nucleus for gene transcription, β Rac1 and PIP5K, and PIP5K promotes membrane localization of these whereas non-canonical Wnt signaling is -catenin independent and complexes in a Rac1-dependent manner. Importantly, the localization involves assembly/disassembly of the actin cytoskeleton, polarized of Daam2 complexes and Daam2-mediated canonical Wnt signaling is cell shape changes and cell migration (Niehrs, 2012; Schlessinger dependent upon actin polymerization. -
Actin-Bound Structures of Wiskott–Aldrich Syndrome Protein (WASP)-Homology Domain 2 and the Implications for Filament Assembly
Actin-bound structures of Wiskott–Aldrich syndrome protein (WASP)-homology domain 2 and the implications for filament assembly David Chereau, Frederic Kerff, Philip Graceffa, Zenon Grabarek, Knut Langsetmo, and Roberto Dominguez* Boston Biomedical Research Institute, 64 Grove Street, Watertown, MA 02472 Edited by Thomas D. Pollard, Yale University, New Haven, CT, and approved September 28, 2005 (received for review August 12, 2005) Wiskott–Aldrich syndrome protein (WASP)-homology domain 2 It has been proposed, based on sequence analysis, that WH2 (WH2) is a small and widespread actin-binding motif. In the WASP forms part of an extended family with the thymosin  domain family, WH2 plays a role in filament nucleation by Arp2͞3 complex. (T) (7). However, this view is controversial, in part because of Here we describe the crystal structures of complexes of actin with the different biological functions and low sequence similarity of the WH2 domains of WASP, WASP-family verprolin homologous WH2 and T (8). The actin-bound structures of the N-terminal protein, and WASP-interacting protein. Despite low sequence iden- half of ciboulot domain 1 (9) and that of a hybrid protein tity, WH2 shares structural similarity with the N-terminal portion of consisting of gelsolin domain 1 and the C-terminal half of T4 the actin monomer-sequestering thymosin  domain (T). We (10) have been reported. These structures have been combined show that both domains inhibit nucleotide exchange by targeting into a model of T4–actin (10), and, although both T4 and the cleft between actin subdomains 1 and 3, a common binding site ciboulot belong in the T family, their structures have been for many unrelated actin-binding proteins. -
The Ubiquitin-Proteasome Pathway Mediates Gelsolin Protein Downregulation in Pancreatic Cancer
The Ubiquitin-Proteasome Pathway Mediates Gelsolin Protein Downregulation in Pancreatic Cancer Xiao-Guang Ni,1 Lu Zhou,2 Gui-Qi Wang,1 Shang-Mei Liu,3 Xiao-Feng Bai,4 Fang Liu,5 Maikel P Peppelenbosch,2 and Ping Zhao4 1Department of Endoscopy, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 2Department of Cell Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 3Department of Pathology, 4Department of Abdominal Surgery, and 5State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China A well-known observation with respect to cancer biology is that transformed cells display a disturbed cytoskeleton. The under- lying mechanisms, however, remain only partly understood. In an effort to identify possible mechanisms, we compared the pro- teome of pancreatic cancer with matched normal pancreas and observed diminished protein levels of gelsolin—an actin fila- ment severing and capping protein of crucial importance for maintaining cytoskeletal integrity—in pancreatic cancer. Additionally, pancreatic ductal adenocarcinomas displayed substantially decreased levels of gelsolin as judged by Western blot and immunohistochemical analyses of tissue micoarrays, when compared with cancerous and untransformed tissue from the same patients (P < 0.05). Importantly, no marked downregulation of gelsolin mRNA was observed (P > 0.05), suggesting that post- transcriptional mechanisms mediate low gelsolin protein levels. In apparent agreement, high activity ubiquitin-proteasome path- way in both patient samples and the BxPC-3 pancreatic cancer cell line was detected, and inhibition of the 26s proteasome sys- tem quickly restored gelsolin protein levels in the latter cell line. -
Familial Adenomatous Polyposis Polymnia Galiatsatos, M.D., F.R.C.P.(C),1 and William D
American Journal of Gastroenterology ISSN 0002-9270 C 2006 by Am. Coll. of Gastroenterology doi: 10.1111/j.1572-0241.2006.00375.x Published by Blackwell Publishing CME Familial Adenomatous Polyposis Polymnia Galiatsatos, M.D., F.R.C.P.(C),1 and William D. Foulkes, M.B., Ph.D.2 1Division of Gastroenterology, Department of Medicine, The Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada, and 2Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada Familial adenomatous polyposis (FAP) is an autosomal-dominant colorectal cancer syndrome, caused by a germline mutation in the adenomatous polyposis coli (APC) gene, on chromosome 5q21. It is characterized by hundreds of adenomatous colorectal polyps, with an almost inevitable progression to colorectal cancer at an average age of 35 to 40 yr. Associated features include upper gastrointestinal tract polyps, congenital hypertrophy of the retinal pigment epithelium, desmoid tumors, and other extracolonic malignancies. Gardner syndrome is more of a historical subdivision of FAP, characterized by osteomas, dental anomalies, epidermal cysts, and soft tissue tumors. Other specified variants include Turcot syndrome (associated with central nervous system malignancies) and hereditary desmoid disease. Several genotype–phenotype correlations have been observed. Attenuated FAP is a phenotypically distinct entity, presenting with fewer than 100 adenomas. Multiple colorectal adenomas can also be caused by mutations in the human MutY homologue (MYH) gene, in an autosomal recessive condition referred to as MYH associated polyposis (MAP). Endoscopic screening of FAP probands and relatives is advocated as early as the ages of 10–12 yr, with the objective of reducing the occurrence of colorectal cancer. -
Alpha-Actinin-3 R577X
Annals of Applied Sport Science, vol. 4, no. 4, pp. 01-06, Winter 2016 DOI: 10.18869/acadpub.aassjournal.4.4.1 Short Communication www.aassjournal.com www.AESAsport.com ISSN (Online): 2322 – 4479 Received: 20/03/2016 ISSN (Print): 2476–4981 Accepted: 10/06/2016 Alpha-actinin-3 R577X Polymorphism Profile of Turkish Professional Hip-Hop and Latin Dancers 1,2 * 1 1 2 1 1 Korkut Ulucan , Betul Biyik, Sezgin Kapici, Canan Sercan, Oznur Yilmaz, Tunc Catal 1Üsküdar Univerity, Haluk Turksoy Sok. No:14, Altunizade, Üsküdar, İstanbul, Turkey. 2Marmara University, BAsibuyuk Yolu 9/3 MAltepe Saglık Yerleşkesi, MAltepe, Istanbul, Turkey. ABSTRACT Actins are small globular filaments functioning in cell processes like muscle contraction, and stabilized to the sarcomeric Z- discs by actin binding proteins (actinins). One of the important gene coding for actin binding proteins in fast twitch fibers is alpha- actinin- 3 (ACTN3). In this research, we have conducted a gene profile study investigating the genotype and allele distributions of ACTN3 R577X polymorphism in Turkish professional hip- hop and latin dancers and compared them to non-dancers as a control group. 30 professional dancers and non-dancers were recruited for the study. A genotyping procedure was carried out by a newly introduced four-primer PCR methodology. For statistical analysis, the Chi-square test was used to compare data between the groups (p<0,05 evaluated as significant). Numbers and the percentages of dancers were 2 (7%), 21 (70%) and 7(23%) for RR, RX and XX genotypes, respectively. The same numbers and the percentages were 15 (50%), 8 (15%) and 7 (23%) for RR, RX and XX genotypes, respectively, for the controls. -
Troponin Variants in Congenital Myopathies: How They Affect Skeletal Muscle Mechanics
International Journal of Molecular Sciences Review Troponin Variants in Congenital Myopathies: How They Affect Skeletal Muscle Mechanics Martijn van de Locht , Tamara C. Borsboom, Josine M. Winter and Coen A. C. Ottenheijm * Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Location VUmc, 1081 HZ Amsterdam, The Netherlands; [email protected] (M.v.d.L.); [email protected] (T.C.B.); [email protected] (J.M.W.) * Correspondence: [email protected]; Tel.: +31-(0)-20-444-8123 Abstract: The troponin complex is a key regulator of muscle contraction. Multiple variants in skeletal troponin encoding genes result in congenital myopathies. TNNC2 has been implicated in a novel congenital myopathy, TNNI2 and TNNT3 in distal arthrogryposis (DA), and TNNT1 and TNNT3 in nemaline myopathy (NEM). Variants in skeletal troponin encoding genes compromise sarcomere function, e.g., by altering the Ca2+ sensitivity of force or by inducing atrophy. Several potential therapeutic strategies are available to counter the effects of variants, such as troponin activators, introduction of wild-type protein through AAV gene therapy, and myosin modulation to improve muscle contraction. The mechanisms underlying the pathophysiological effects of the variants in skeletal troponin encoding genes are incompletely understood. Furthermore, limited knowledge is available on the structure of skeletal troponin. This review focusses on the physiology of slow and fast skeletal troponin and the pathophysiology of reported variants in skeletal troponin encoding genes. A better understanding of the pathophysiological effects of these variants, together with enhanced knowledge regarding the structure of slow and fast skeletal troponin, will direct the development of Citation: van de Locht, M.; treatment strategies. -
Serial Analysis of Gene Expression in Normal P53 Null Mammary Epithelium
Oncogene (2002) 21, 6366 – 6376 ª 2002 Nature Publishing Group All rights reserved 0950 – 9232/02 $25.00 www.nature.com/onc Serial analysis of gene expression in normal p53 null mammary epithelium C Marcelo Aldaz*,1, Yuhui Hu1, Rachael Daniel1, Sally Gaddis1, Frances Kittrell2 and Daniel Medina2 1The University of Texas M.D. Anderson Cancer Center, Department of Carcinogenesis, Smithville, Texas, TX 78957, USA; 2Baylor College of Medicine Department of Molecular and Cellular Biology, Houston, Texas, TX 77030, USA Much evidence has accumulated implicating the p53 gene function although activating mutations were also as of importance in breast carcinogenesis. However, observed. Usually p53 abnormalities associate with much still remains to be uncovered on the specific poorer clinical outcome. This, likely, is the consequence downstream pathways influenced by this important of the known critical roles of p53 in regulating the cell activator/repressor of transcription. This study investi- cycle, apoptosis, DNA repair and maintaining genome gated the effects of a p53 null genotype on the stability (Levine, 1997). The loss of wild type p53 transcriptome of ‘normal’ mouse mammary epithelium function is clearly an important event in breast using a unique in vivo model of preneoplastic transforma- tumorigenesis as documented both in human and murine tion. We used SAGE for the comparative analysis of p53 systems (Donehower et al., 1995; Elledge and Allred, wild type (wt) and null mammary epithelium unexposed 1994). However, the exact mechanisms by which such and exposed to hormonal stimulation. Analysis of the lack of normal gene function leads to cancer formation hormone exposed samples provided a comprehensive view and progression are only beginning to be understood. -
Evidence for Rho Kinase Pathway
Oncogene (2001) 20, 2112 ± 2121 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway Vanya Shah3, Shantaram Bharadwaj1,2, Kozo Kaibuchi4 and GL Prasad*,1,2 1Department of General Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina, NC 27157, USA; 2Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, NC 27157, USA; 3Wistar Institute of Anatomy and Cell Biology, Philadelphia, Pennsylvania, USA; 4Nara Institute of Science and Technology Ikoma, Japan Tropomyosin (TM) family of cytoskeletal proteins is and tropomyosins (TMs) are suppressed to varying implicated in stabilizing actin micro®laments. Many TM degrees in many transformed cells (Ben-Ze'ev, 1997). isoforms, including tropomyosin-1 (TM1), are down- Furthermore, restoration of these proteins inhibits the regulated in transformed cells. Previously we demon- malignant phenotype of many dierent experimentally strated that TM1 is a suppressor of the malignant transformed cell lines, underscoring the pivotal role of transformation, and that TM1 reorganizes micro®la- cytoskeletal organization in maintaining a normal ments in the transformed cells. To investigate how TM1 phenotype (Ayscough, 1998; Janmey and Chaponnier, induces micro®lament organization in transformed cells, 1995). Our laboratory has been interested in under- we utilized ras-transformed NIH3T3 (DT) cells, and standing the role of cytoskeletal proteins, in particular those transduced to express TM1, and/or TM2. that of tropomyosins, in malignant transformation. Enhanced expression of TM1 alone, but not TM2, Tropomyosin (TM) family comprises of 5 ± 7 results in re-emergence of micro®laments; TM1, together dierent closely related isoforms, whose expression is with TM2 remarkably improves micro®lament architec- altered in many transformed cells (Lin et al., 1997; ture. -
Mini-Thin Filaments Regulated by Troponin–Tropomyosin
Mini-thin filaments regulated by troponin–tropomyosin Huiyu Gong*, Victoria Hatch†, Laith Ali‡, William Lehman†, Roger Craig§, and Larry S. Tobacman‡¶ *Department of Internal Medicine, University of Iowa, Iowa City, IA 52242; †Department of Physiology and Biophysics, Boston University, Boston, MA 02118; §Department of Cell Biology, University of Massachusetts, Worcester, MA 01655; and ‡Departments of Medicine and Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL 60612 Edited by Edward D. Korn, National Institutes of Health, Bethesda, MD, and approved December 9, 2004 (received for review September 29, 2004) Striated muscle thin filaments contain hundreds of actin monomers normal-length thin filaments. They also would make possible and scores of troponins and tropomyosins. To study the coopera- approaches to thin-filament structural analysis. We report here tive mechanism of thin filaments, ‘‘mini-thin filaments’’ were the design and purification of mini-thin filaments with the generated by isolating particles nearly matching the minimal intended composition and compare their function to the function structural repeat of thin filaments: a double helix of actin subunits of conventional-length thin filaments. with each strand approximately seven actins long and spanned by Ca2ϩ regulates muscle contraction in the heart and in skeletal a troponin–tropomyosin complex. One end of the particles was muscle by binding to specific site(s) in the NH2 domain of the capped by a gelsolin (segment 1–3)–TnT fusion protein (substitut- troponin subunit, TnC. Significantly, Ca2ϩ activates tension very ing for normal TnT), and the other end was capped by tropomodu- cooperatively (3, 4) even in cardiac muscle, in which each TnC lin. -
Regulation of Titin-Based Cardiac Stiffness by Unfolded Domain Oxidation (Undox)
Regulation of titin-based cardiac stiffness by unfolded domain oxidation (UnDOx) Christine M. Loeschera,1, Martin Breitkreuzb,1, Yong Lia, Alexander Nickelc, Andreas Ungera, Alexander Dietld, Andreas Schmidte, Belal A. Mohamedf, Sebastian Kötterg, Joachim P. Schmitth, Marcus Krügere,i, Martina Krügerg, Karl Toischerf, Christoph Maackc, Lars I. Leichertj, Nazha Hamdanib, and Wolfgang A. Linkea,2 aInstitute of Physiology II, University of Munster, 48149 Munster, Germany; bInstitute of Physiology, Ruhr University Bochum, 44801 Bochum, Germany; cComprehensive Heart Failure Center Wuerzburg, University Clinic Wuerzburg, 97078 Wuerzburg, Germany; dDepartment of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany; eInstitute for Genetics, University of Cologne, 50931 Cologne, Germany; fDepartment of Cardiology and Pneumology, University Medicine Goettingen, 37075 Goettingen, Germany; gDepartment of Cardiovascular Physiology, Heinrich Heine University, 40225 Düsseldorf, Germany; hDepartment of Pharmacology and Clinical Pharmacology, Heinrich Heine University, 40225 Düsseldorf, Germany; iCenter for Molecular Medicine and Excellence Cluster "Cellular Stress Responses in Aging-Associated Diseases" (CECAD), University of Cologne, 50931 Cologne, Germany; and jInstitute for Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801 Bochum, Germany Edited by Jonathan Seidman, Harvard University, Boston, MA, and approved August 12, 2020 (received for review March 14, 2020) The relationship between oxidative stress and